切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MCL1 - Bcl-xl - MDM2 - adrenergic receptor

11件产品中的 1-10

页面
每页
清除全部
  1. S63845
    A8737 S63845
     11 Citation
    Target: MCL1
    Summary: MCL1抑制剂
      ≥41.45 mg/mL
      insoluble in H2O
  2. Epinephrine Bitartrate
    B1358 Epinephrine Bitartrate
    中文名: 酒石酸肾上腺素
    Target: adrenergic receptor
    Summary: 肾上腺素能受体激动剂
      ≥16.66 mg/mL
      ≥22.9 mg/mL
  3. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  4. WEHI-539
    A3935 WEHI-539
     15 Citation
    Target: Bcl-xl
    Summary: 选择性的Bcl-xL抑制剂
      insoluble in DMSO
      insoluble in H2O
  5. RG7112
    A3762 RG7112
     5 Citation
    Target: MDM2
    Summary: MDM2抑制剂
      ≥36.4 mg/mL
      insoluble in H2O
  6. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O
  7. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O
  8. Apogossypolone (ApoG2)
    A4200 Apogossypolone (ApoG2)
     2 Citation
    Target: Bcl-2|Bcl-xl|Mcl-1
    Summary: Bcl-2的非肽类小分子抑制剂
      ≥24.55 mg/mL
      insoluble in H2O
  9. TW-37
    A4234 TW-37
     1 Citation
    Target: Bcl-2|Bcl-xl|Mcl-1
    Summary: Bcl-2抑制剂,抑制Bcl-2、Bcl-XL和Mcl-1。
      ≥19.75 mg/mL
      insoluble in H2O
  10. Nutlin-3
    A4228 Nutlin-3
    Target: MDM2
    Summary: MDM2 拮抗剂
      ≥58.2 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页